Recombinant Human IL32 Protein, His-tagged

• Cat.No.: IL32-151H
• Product Overview: Recombinant Human interleukin 32(IL32) protein, transcript variant 8(NM_001012718), with a His tag, was expressed in human cells.

Specification

• Description: This gene encodes a member of the cytokine family. The protein contains a tyrosine sulfation site, 3 potential N-myristoylation sites, multiple putative phosphorylation sites, and an RGD cell-attachment sequence. Expression of this protein is increased after the activation of T-cells by mitogens or the activation of NK cells by IL-2. This protein induces the production of TNFalpha from macrophage cells. Alternate transcriptional splice variants, encoding different isoforms, have been characterized.
• Source: Human cells
• Species: Human
• Tag: His
• Form: Purified protein formulated in a sterile solution of TBS buffer, pH7.110, without any preservatives.
• Molecular Mass: 21.6 kDa
• Endotoxin: Endotoxin level is < 0.1 ng/µg of protein (<1EU /µg)
• Purity: >90% by SDS-PAGE gel and Coomassie Blue staining
• Applications: Antigens, Western, ELISA and other in vitro binding or in vivo functional assays, and protein-protein interaction studies.

Gene Information

• Gene Name: IL32 interleukin 32 [ Homo sapiens ]
• Official Symbol: IL32
• Synonyms: IL32; interleukin 32; interleukin-32; natural killer cell transcript 4; NK4; TAIF; TAIFb; TAIFd; interleukin-32 eta; interleukin-32 small; interleukin-32 theta; natural killer cells protein 4; tumor necrosis factor alpha-inducing factor; TAIFa; TAIFc; IL-32beta; IL-32alpha; IL-32delta; IL-32gamma
• Gene ID: 9235
• mRNA Refseq: NM_001012631
• Protein Refseq: NP_001012649
• MIM: 606001
• UniProt ID: P24001

Reviews

12/13/2022

IL32 protein has a long shelf life, which facilitates the continuity of subsequent experiments.

05/20/2022

Consistent results can be obtained using IL32 experiments and experimental uncertainty can be reduced.

10/26/2019

The IL32 shows excellent stability and repeatability under specific experimental conditions.

Q&As

Can recombinant IL32 be used to treat autoimmune diseases?

At present, research is ongoing, and IL32 is considered to have the potential to treat autoimmune diseases, but further clinical validation is required.

What is IL32?

IL32, a protein of human origin, is an interferon-induced cytokine with a variety of biological functions.

What is the progress of IL32 in clinical trials?

IL32 is in clinical trials and will take time to evaluate its safety and efficacy.

Is recombinant IL32 associated with inflammation?

IL32 induce and regulate inflammatory response and participate in immune and inflammatory processes.

Can IL32 improve immunity?

Can enhance the activity and function of immune cells, thereby improving the body immunity.

What are the side effects of IL32?

So far, there have been no clear reports of side effects of IL32, but attention should be paid to reasonable dosage and method of use when using it.